Skip to search formSkip to main contentSkip to account menu

CI-1028

National Institutes of Health

Related topics

Related topics

1 relation
LB 30057

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Antithrombotic Effect of LB-30057 (CI-1028), a New Synthetic Thrombin Inhibitor, in a Rabbit Model of Thrombosis: Comparison with Inogatran
LB-30057 (CI-1028) is a novel, orally bioavailable, direct thrombin inhibitor with a Ki of 0.38[emsp4 ]nM against human thrombin… 
2000
2000
The Antithrombotic Effects of CI-1028, an Orally Bioavailable Direct Thrombin Inhibitor, in a Canine Model of Venous and Arterial Thrombosis
Direct thrombin inhibitors represent a new class of drug that may offer a therapeutic alternative for the treatment and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)